Fig. 2.
Fig. 2. CPLA2 in neutrophils during sepsis and after recovery. / (A) Immunoblot analysis of cPLA2 in neutrophil lysates of septic patients during infection and after recovery. Shown are the results of a representative patient with sepsis and a representative patient with sepsis+bacteremia during the disease (“D”) and after complete recovery (“A”). (B) cPLA2 expression in human neutrophils during sepsis and after recovery (expressed in densitometry units). The mean ± SEM of the densitometry values in the septic patients who showed increased cPLA2 activity and the controls are shown. (C) cPLA2 activity in neutrophil lysates during sepsis and after recovery. The mean ± SEM of cPLA2 activities in neutrophil of the individual patients who showed increased cPLA2 activity (Figure 1) and of the controls are shown.

CPLA2 in neutrophils during sepsis and after recovery.

(A) Immunoblot analysis of cPLA2 in neutrophil lysates of septic patients during infection and after recovery. Shown are the results of a representative patient with sepsis and a representative patient with sepsis+bacteremia during the disease (“D”) and after complete recovery (“A”). (B) cPLA2 expression in human neutrophils during sepsis and after recovery (expressed in densitometry units). The mean ± SEM of the densitometry values in the septic patients who showed increased cPLA2 activity and the controls are shown. (C) cPLA2 activity in neutrophil lysates during sepsis and after recovery. The mean ± SEM of cPLA2 activities in neutrophil of the individual patients who showed increased cPLA2 activity (Figure 1) and of the controls are shown.

Close Modal

or Create an Account

Close Modal
Close Modal